-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OFPoMMTSG47nkC/57RJTP6Vh5o0uljMHmw+fihI5lJ8oO0e+iHP+b+oWnR4+uT6P H55+31kbryS06QzVuhWjgQ== 0001209191-07-064133.txt : 20071115 0001209191-07-064133.hdr.sgml : 20071115 20071115134301 ACCESSION NUMBER: 0001209191-07-064133 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071113 FILED AS OF DATE: 20071115 DATE AS OF CHANGE: 20071115 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MERCK & CO INC CENTRAL INDEX KEY: 0000064978 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221109110 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MERCK DR STREET 2: P O BOX 100 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 BUSINESS PHONE: 9084231688 MAIL ADDRESS: STREET 1: ONE MERCK DR STREET 2: PO BOX 100 WS3AB-05 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KELLOGG PETER N CENTRAL INDEX KEY: 0001226287 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03305 FILM NUMBER: 071248895 BUSINESS ADDRESS: BUSINESS PHONE: 6176792000 MAIL ADDRESS: STREET 1: BIOGEN INC LEGAL DEPARTMENT STREET 2: 14 CAMBRIDGE CENTER CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2007-11-13 0 0000064978 MERCK & CO INC (MRK) 0001226287 KELLOGG PETER N MERCK & CO., INC. ONE MERCK DRIVE WHITEHOUSE STATION NJ 08889-0100 0 1 0 0 Exec. V.P. & C.F.O. Employee Stock Option 2007/11/13 (right to buy) 57.49 2007-11-13 4 A 0 175000 0.00 A 2008-11-13 2017-11-12 Common Stock 175000 175000 D Restricted Stock Units 2007/11/13 2007-11-13 4 A 0 80000 0.00 A 2010-11-13 2013-11-13 Common Stock 80000 80000 D The option vests in five equal annual installments beginning November 13, 2008. Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. 40,000 restricted stock units will vest on November 13, 2010 and 40,000 restricted stock units will vest on November 13, 2013. Debra A. Bollwage as Attorney-in-Fact for Peter N. Kellogg 2007-11-15 -----END PRIVACY-ENHANCED MESSAGE-----